Scale up and scale out with practicality, speed, and consistency.
The ScaleReady platform is thoughtfully designed around G-Rex® closed-system bioreactors to minimize process development time and batch failure rate. Get therapies to the clinic faster with a practical, scalable footprint.
Maintain high cell quality from research bench to clinical bedside.
Cell phenotype drift during scale-up is avoidable. G-Rex bioreactors, combined with high-quality reagents, maintain cell phenotype profiles across small and large scale expansion.
GMP raw materials for any process at any scale.
Raw material quality, supply, and process fit won’t be an issue. ScaleReady’s adaptable workflow, flexible filling, and supply agreements for GMP reagents ensure process customization and supply security as you scale.
The ScaleReady partners united to transform cell and gene therapy manufacturing with thoughtful leadership and design.
Latest ScaleReady news and events.
10 November 2021
ScaleReady Launches Second Generation of Wilson Wolf G-Rex Product
3 November 2021
Bio-Techne Releases First GMP-grade Cytokines from New GMP Facility
7 October 2021
CancerNetworks Interviews ScaleReady
Get in touch to begin scaling up and scaling out.
Let’s talk more about how ScaleReady can advance your cell and gene therapy research and manufacturing with ingenious efficiency.